FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

332965002: Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3763220019 Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3763221015 Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Is a Product containing undecenoate (product) false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Undecenoate (substance) false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Is a Product containing undecylenic acid and zinc undecylenate false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Undecylenic acid and zinc undecylenate false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has manufactured dose form forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Is a Topical antifungal false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zinc undecylenate false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Undecylenic acid (substance) false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has manufactured dose form Cutaneous powder true Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Is a Product containing zinc in topical dosage form false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder This attribute specifies the numerator unit for the concentration strength of a product. mcg true Inferred relationship Some 1
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has concentration strength denominator value un false Inferred relationship Some 2
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Is a Product containing only undecylenic acid in cutaneous dose form (medicinal product form) false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder This attribute specifies the denominator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has concentration strength denominator value un false Inferred relationship Some 1
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder This attribute specifies the denominator unit for the concentration strength of a product. mg true Inferred relationship Some 2
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Count of base of active ingredient un false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder This attribute specifies the numerator unit for the concentration strength of a product. mcg true Inferred relationship Some 2
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Zinc undecylenate true Inferred relationship Some 2
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Zinc undecylenate true Inferred relationship Some 2
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has concentration strength numerator value 200 false Inferred relationship Some 2
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Undecylenic acid (substance) true Inferred relationship Some 1
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Undecylenic acid (substance) true Inferred relationship Some 1
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Has concentration strength numerator value 50 false Inferred relationship Some 1
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Count of base of active ingredient deux false Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Is a Undecylenic acid-containing product in cutaneous dose form true Inferred relationship Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder Plays role Antifungal therapeutic role (role) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start